Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Rocket
1980.2000 -20.50 (-1.02%)
NSE Nov 17, 2026 15:31 PM
Volume: 107.6K
 

1980.20
-1.02%
Emkay
Following the slump in FY23, DLPL has registered revenue/EBITDA/PAT CAGR of 10%/19%/43%, respectively, over the last two years.
Dr. Lal Pathlabs has gained 23.54% in the last 6 Months
More from Dr. Lal Pathlabs Ltd.
Recommended